PMID: 6107679Nov 15, 1980Paper

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians

Lancet
D J PettittP H Bennett

Abstract

The risks of microvascular complications over periods of 3 and 6 years in relation to baseline plasma glucose concentrations were estimated in Pima Indians of Arizona aged 25 years or more and who were not taking hypoglycaemic medicine at their initial examinations. Retinopathy (microaneurysms, haemorrhages, or neovascularisation) developed within 3 years in 1% of 181 subjects with initial fasting plasma glucose concentrations less than 140 mg/dl (1 mg/dl = 0.0555 mmol/l) and in 13% of 39 subjects with higher initial fasting plasma glucose levels. No one with an initial 2 h glucose concentration less than 200 mg/dl had retinopathy within 3 years, but the rate was 12% in 60 subjects with higher glucose concentrations. Retinopathy developed within 6 years in 1% of 446 subjects whose 2 h post-load glucose concentrations were less than 200 mg/dl and in 20% of 113 subjects with higher levels. Subsequent development of heavy proteinuria (urine protein/creatinine ratio at least 1.0) was less common than that of retinopathy, but was similarly related to the initial fasting and 2 h plasma glucose concentrations. The finding that these microvascular complications rarely appeared in individuals with fasting plasma glucose concentrations l...Continue Reading

Citations

Feb 1, 1990·Diabetes/metabolism Reviews·W C KnowlerP H Bennett
Mar 1, 1990·Diabetes/metabolism Reviews·P ZimmetH King
Feb 1, 1983·Diabetologia·V MassariA J Valleron
Mar 1, 1986·Journal of General Internal Medicine·C D Mulrow, M J Lichtenstein
Oct 1, 1996·Diabetes Research and Clinical Practice·D GohdesS Rith-Najarian
Aug 12, 2000·Journal of General Internal Medicine·M B DavidsonB Lorber
Jan 11, 2000·QJM : Monthly Journal of the Association of Physicians·F De LorenzoV V Kakkar
Jan 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·D A RobertsonH Gareeboo
Nov 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Andrew F B KernohanMichael Small
Mar 16, 2005·Treatments in Endocrinology·Rajasekaran Sudhir, Viswanathan Mohan
Jan 29, 2011·Diabetes Care·Mayer B Davidson
Feb 27, 2013·Annals of Medical and Health Sciences Research·Hari Kvs KumarKd Modi
Feb 28, 2002·BMC Endocrine Disorders·Ali ParappilKamal AS Al-Shoumer
Jul 1, 1982·Clinics in Endocrinology and Metabolism·H Keen, S Ng Tang Fui
Dec 1, 1981·Journal of Clinical and Hospital Pharmacy·A D Wright
Aug 31, 2002·Diabetes/metabolism Research and Reviews·Philip HomeUNKNOWN Worldwide Initiative for Diabetes Education (WorldWIDE)
Apr 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·K F ErikssonG Sundkvist
Oct 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·P O BitzénM Svensson
Apr 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·M FarrerK G Alberti
Apr 2, 2004·The British Journal of Psychiatry. Supplement·Richard I G Holt
Jun 9, 2009·Diabetes Care·UNKNOWN International Expert Committee
Sep 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·R R Holman, R C Turner
Jul 1, 1981·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R W Stout
Mar 1, 1996·The Journal of International Medical Research·S OkadaZ Ota
Jul 17, 2001·Journal of Biomedical Science·C E Ezenwaka, N V Offiah
May 1, 1986·Diabetic Medicine : a Journal of the British Diabetic Association·R C TurnerW J Braund
Jan 1, 1985·Diabetic Medicine : a Journal of the British Diabetic Association·R R Holman, R C Turner
Oct 1, 1996·Annals of Medicine·R C Turner, R R Holman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.